Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dwight D Harris

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Bioengineering (Basel, Switzerland)|January 28, 2026
Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant ModelsKelsey C Muir, Clark Zheng, Keertana Yalamanchili, et al.
European Journal of Pharmacology|July 19, 2025
Sodium-glucose Cotransporter-2 Canagliflozin's impact on cardiovascular disease in the setting of metabolic syndrome: A proteomic analysisJad Hamze, Dwight D Harris, Christopher Stone, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2025
Sotagliflozin Enhances Left Ventricular Function and Myocardial Perfusion in Chronic Myocardial Ischemia Through Metabolic and Redox RemodelingKelsey C Muir, Christopher Stone, Riya Reddy, et al.
Plos One|July 29, 2024
Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemiaDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 19, 2026
Semaglutide Augments Vascular Proliferation and Cardiac Performance in a Large Animal Model of Ischemic CardiomyopathyKelsey C Muir, Christopher R Stone, Dwight D Harris, et al.
The Journal of Surgical Research|October 22, 2024
Sodium-Glucose Cotransporter-2 Inhibition Normalizes Metabolic Derangements in the Ischemic MyocardiumChristopher Stone, Dwight D Harris, Mark Broadwin, et al.
The Journal of Surgical Research|April 20, 2025
Linagliptin Modulation of Inflammation in Chronic Coronary Artery DiseaseKelsey C Muir, Dwight D Harris, Christopher Stone, et al.
The Journal of Surgical Research|April 30, 2022
Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and NonpatientsDwight D Harris, Aaron Fleishman, Martha Pavlakis, et al.
Journal of the American College of Surgeons|December 9, 2024
Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic Ischemia/Reperfusion in Non-Diabetic and Diabetic Human Coronary Arterial Endothelial CellsJu-Woo Nho, Debolina Banerjee, Dwight D Harris, et al.
Vessel Plus|August 23, 2024
Comparative effects of canagliflozin and sitagliptin in chronically ischemic myocardiumSharif A Sabe, Dwight D Harris, Mark Broadwin, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Bioengineering (Basel, Switzerland)|January 28, 2026
Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant ModelsKelsey C Muir, Clark Zheng, Keertana Yalamanchili, et al.
European Journal of Pharmacology|July 19, 2025
Sodium-glucose Cotransporter-2 Canagliflozin's impact on cardiovascular disease in the setting of metabolic syndrome: A proteomic analysisJad Hamze, Dwight D Harris, Christopher Stone, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2025
Sotagliflozin Enhances Left Ventricular Function and Myocardial Perfusion in Chronic Myocardial Ischemia Through Metabolic and Redox RemodelingKelsey C Muir, Christopher Stone, Riya Reddy, et al.
Plos One|July 29, 2024
Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemiaDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 19, 2026
Semaglutide Augments Vascular Proliferation and Cardiac Performance in a Large Animal Model of Ischemic CardiomyopathyKelsey C Muir, Christopher R Stone, Dwight D Harris, et al.
The Journal of Surgical Research|October 22, 2024
Sodium-Glucose Cotransporter-2 Inhibition Normalizes Metabolic Derangements in the Ischemic MyocardiumChristopher Stone, Dwight D Harris, Mark Broadwin, et al.
The Journal of Surgical Research|April 20, 2025
Linagliptin Modulation of Inflammation in Chronic Coronary Artery DiseaseKelsey C Muir, Dwight D Harris, Christopher Stone, et al.
The Journal of Surgical Research|April 30, 2022
Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and NonpatientsDwight D Harris, Aaron Fleishman, Martha Pavlakis, et al.
Journal of the American College of Surgeons|December 9, 2024
Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic Ischemia/Reperfusion in Non-Diabetic and Diabetic Human Coronary Arterial Endothelial CellsJu-Woo Nho, Debolina Banerjee, Dwight D Harris, et al.
Vessel Plus|August 23, 2024
Comparative effects of canagliflozin and sitagliptin in chronically ischemic myocardiumSharif A Sabe, Dwight D Harris, Mark Broadwin, et al.
Pageof 6